Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.
Saved in:
| Title: | Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results. |
|---|---|
| Authors: | Heczey A; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA. heczey@bcm.edu.; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA. heczey@bcm.edu., Xu X; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Courtney AN; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Tian G; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Barragan GA; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Guo L; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Amador CM; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Ghatwai N; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Rathi P; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Wood MS; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Li Y; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Zhang C; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Demberg T; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Di Pierro EJ; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Sher AC; Department of Radiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Zhang H; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Mehta B; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Thakkar SG; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Grilley B; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Wang T; Biostatistics and Data Management Resource, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Weiss BD; Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH, USA., Montalbano A; Immunai, Inc., New York, NY, USA., Subramaniam M; Immunai, Inc., New York, NY, USA., Xu C; Immunai, Inc., New York, NY, USA., Sachar C; Immunai, Inc., New York, NY, USA., Wells DK; Immunai, Inc., New York, NY, USA., Dotti G; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Metelitsa LS; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA. lsmeteli@txch.org.; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA. lsmeteli@txch.org. |
| Source: | Nature medicine [Nat Med] 2023 Jun; Vol. 29 (6), pp. 1379-1388. Date of Electronic Publication: 2023 May 15. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
